Kearny Venture Partners is a venture capital firm based in San Francisco, California. The firm focuses on companies operating in the healthcare product sector.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Cybin | 04-Feb-2021 | PIPE | 000.00 | Drug Discovery | Generating Revenue/Not Profitable | |
| 00000 | 19-Oct-2020 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue/Not Profitable | |
| 00000000 | 12-Nov-2019 | 00000 00000 | 00000 | Business/Productivity Software | Generating Revenue | |
| 0000000 | 23-Oct-2017 | 0000 | 000.00 | Other Devices and Supplies | Generating Revenue/Not Profitable | 00000 000000000 00 |
| 000000 | 16-Mar-2017 | 0000 | 0000 | Drug Discovery | Generating Revenue/Not Profitable | 000000 00000 00 |
| 0000000 | 19-Aug-2016 | 0000 | 0000 | Other Devices and Supplies | Generating Revenue/Not Profitable | 00000 000000000 00 |
| 0000000 | 19-Aug-2015 | 0000 | 000.00 | Other Devices and Supplies | Generating Revenue/Not Profitable | 00000 000000000 00 |
| 000000 | 23-Apr-2014 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue/Not Profitable | 000000 00000 00 |
| ViewRay | 03-Dec-2013 | Later Stage VC | 0000 | Other Devices and Supplies | Generating Revenue/Not Profitable | 00000 000000000 00 |
| TriVascular | 07-Nov-2013 | Restart - Later VC | 000.00 | Surgical Devices | Generating Revenue/Not Profitable | 000 0000000 |
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| PROCEPT BioRobotics | 15-Sep-2021 | IPO | 00000 |
| 0000 | 30-Jun-2021 | 000 | 00000 |
| 0000000 0000000000 | 27-Dec-2019 | 0000000000: 000000 | |
| 0000000 | 13-Jan-2019 | 000000000 00000000 | |
| 00000 000000000000 | 13-Dec-2018 | 000000000000000000 | 00.00 |
| 00000 000000000000 | 01-Dec-2017 | 000000000000000000 | 00000 |
| 0000000 0000000000 | 03-Nov-2017 | 0000000 000000 | |
| 000000 00000000000 | 26-May-2017 | 000000 0000000000 | 000 |
| QuatRx Pharmaceuticals | 10-Mar-2017 | Merger/Acquisition | |
| Intact Medical | 01-Aug-2016 | Merger/Acquisition |
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is available in the PitchBook Platform. To explore Kearny Venture Partners‘s full profile, request access.
Request a free trialInvestments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trial| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Andrew Jensen | Chief Financial Officer | 0 | San Francisco, CA | ||
| Jim Shapiro | Managing Director | 0 | 0 | San Francisco, CA | |
| Caley Castelein MD | Partner, Managing Member & Founder | 0 | 0 | 0 | San Francisco, CA |
| Joe LaHorgue | Executive | San Francisco, CA |
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Janus Henderson Investors | 1 |
|
|
||
| Noetic Fund | 0 |
|
|
||
| RA Capital Management | 0 |
|
|
||
| Seed4Soft | 0 | 0 |
|
|
|
| V3 Capital Partners | 0 |
|
|